Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen patents…
The post New patent for Boehringer Ingelheim drug GLYXAMBI appear…
New patent for Boehringer Ingelheim drug GLYXAMBI Read Post »
Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from five suppliers. There are seven patents…
The post New patent for Boehringer Ingelheim drug JARDIANCE appe…
New patent for Boehringer Ingelheim drug JARDIANCE Read Post »
Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post New patent for Boehringer Ingelheim drug JENTADUETO a…
New patent for Boehringer Ingelheim drug JENTADUETO Read Post »
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are ten patents…
The post New patent for Boehringer Ingelheim drug TRADJENTA appeare…
New patent for Boehringer Ingelheim drug TRADJENTA Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Ireland? Read Post »
FERAHEME (ferumoxytol) Covis Patent: 6,599,498 Expiration: Jun 30, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pate…
Drug Patent Expirations for the Week of June 25, 2023 Read Post »
This chart shows the pharmaceutical companies with the most suspension dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suspension dosed drugs…
The post Which pharmaceutical companies have the mos…
Which pharmaceutical companies have the most suspension dosed drugs? Read Post »
FERAHEME (ferumoxytol) Covis Patent: 6,599,498 Expiration: Jun 30, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pate…
Drug Patent Expirations for the Week of June 25, 2023 Read Post »
Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are six patents protecting this drug. This drug has…
The post New patent expiration for Oncopeptides Ab drug PEPAXTO appeared fir…
New patent expiration for Oncopeptides Ab drug PEPAXTO Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Italy? Read Post »
Get new actionable insights and updates from BiotechBlog
